Recent TDSGF News
- Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma • Newsfile • 04/14/2026 11:00:00 AM
- Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman • Newsfile • 03/31/2026 11:00:00 AM
- Telo Genomics Announces Appointment of John Price as Chief Financial Officer • Newsfile • 01/29/2026 01:00:00 PM
- Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program • Newsfile • 12/18/2025 09:05:00 PM
- Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting • Newsfile • 12/11/2025 09:00:00 PM
- Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 12/10/2025 02:57:30 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/10/2025 01:35:00 PM
- Telo Genomics Corp to Present at the Small Cap Growth Virtual Investor Conference December 9th • GlobeNewswire Inc. • 12/08/2025 01:35:00 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/05/2025 01:35:00 PM
- Telo Genomics to Present Groundbreaking Individual-Cell Risk Assessment MRD Technology at the Myeloma Canada MRD Implementation Summit 2025 • Newsfile • 11/13/2025 01:30:00 PM
- American Society of Hematology Accepts Telo Genomics' Abstract for Presentation at its 2025 Meeting and Exposition • Newsfile • 10/09/2025 12:30:00 PM
- Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update • Newsfile • 09/30/2025 08:30:00 PM
